FDA Drug recall D-0654-2021
Poseidon Platinum 3500 capsule, 1-count per blister card, Distributed by: Poseidon, Made in the USA, UPC 0 95842 05876 0
- FDA Drug
- Class I
- terminated
- Published 2021-07-21
On 2021-07-21 the FDA classified a Class I recall of Poseidon Platinum 3500 capsule, 1-count per blister card, Distributed by: Poseidon, Made in the USA, UPC 0 95842 05876 0 by Yamtun7, citing marketed Without An Approved NDA/ANDA: Product found to contain undeclared sildenafil and tadalafil making them unapproved drugs for which the safety and efficacy have not been es….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0654-2021 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2021-05-11 |
| Published | 2021-07-21 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Yamtun7 |
| Distribution | n/a |
Product
Poseidon Platinum 3500 capsule, 1-count per blister card, Distributed by: Poseidon, Made in the USA, UPC 0 95842 05876 0
Reason
Marketed Without An Approved NDA/ANDA: Product found to contain undeclared sildenafil and tadalafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.
Identifiers
| upc | 095842058760 |
|---|---|
| code_info | All lots distributed 07/01/2019 through 09/28/2020. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0654-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.